Cargando…
Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework
BACKGROUND: Post-malaria neurological syndrome (PMNS) is a debated entity, defined by neurological complications following a post-malaria symptom-free period and a negative blood smear. Four cases of PMNS are hereby reported and a review the literature performed to clarify the nosological framework...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204022/ https://www.ncbi.nlm.nih.gov/pubmed/30367650 http://dx.doi.org/10.1186/s12936-018-2542-8 |
_version_ | 1783365982437244928 |
---|---|
author | Tamzali, Yanis Demeret, Sophie Haddad, Elie Guillot, Hélène Caumes, Eric Jauréguiberry, Stéphane |
author_facet | Tamzali, Yanis Demeret, Sophie Haddad, Elie Guillot, Hélène Caumes, Eric Jauréguiberry, Stéphane |
author_sort | Tamzali, Yanis |
collection | PubMed |
description | BACKGROUND: Post-malaria neurological syndrome (PMNS) is a debated entity, defined by neurological complications following a post-malaria symptom-free period and a negative blood smear. Four cases of PMNS are hereby reported and a review the literature performed to clarify the nosological framework of this syndrome. METHODS: A French teaching hospital infectious diseases database was investigated for all PMNS cases occurring between 1999 and 2016 and the PubMed database for cases reported by other institutions after 1997. A case was defined by the de novo appearance of neurological signs following a post-malaria symptom-free period, a negative blood smear, and no bacterial or viral differential diagnoses. RESULTS: Four patients from the database and 48 from PubMed, including 4 following Plasmodium vivax infection were found matching the definition. In the institution, the estimated PMNS incidence rate was 1.7 per 1000 malaria cases overall. Of the 52 patients (mean age 33 years), 65% were men. Malaria was severe in 85% of cases, showed neurological involvement in 53%, and treated with quinine in 60%, mefloquine in 46%, artemisinin derivatives in 41%, antifolic drugs in 30%, doxycycline in 8% and other types in 8%. The mean symptom-free period was 15 days. PMNS signs were confusion (72%), fever (46%), seizures (35%), cerebellar impairment (28%), psychosis (26%), and motor disorders (13%). Cerebrospinal fluid analyses showed high protein levels in 77% (mean 1.88 g/L) and lymphocytic meningitis in 59.5% (mean 48 WBC/mm(3)) of cases. Electroencephalograms were pathological in 93% (14/15) of cases, and brain MRIs showed abnormalities in 43% (9/21) of cases with white matter involvement in 100%. Fourteen patients were treated with steroids. The 18 patients with follow-up data showed no sequelae. The mean time to recovery was 17.4 days. CONCLUSION: PMNS is a rare entity englobing neurological signs after severe or non-severe malaria. It appears after a symptom-free period. PMNS occurred following treatment of malaria with a wide range of anti-malarials. The disease is self-limiting and associated with good outcome. MRI patterns underline a possible link with acute disseminated encephalomyelitis (ADEM) or auto-immune encephalitis. Plasmodium falciparum and Plasmodium vivax should be added to the list of pathogens causing ADEM. |
format | Online Article Text |
id | pubmed-6204022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62040222018-11-01 Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework Tamzali, Yanis Demeret, Sophie Haddad, Elie Guillot, Hélène Caumes, Eric Jauréguiberry, Stéphane Malar J Case Report BACKGROUND: Post-malaria neurological syndrome (PMNS) is a debated entity, defined by neurological complications following a post-malaria symptom-free period and a negative blood smear. Four cases of PMNS are hereby reported and a review the literature performed to clarify the nosological framework of this syndrome. METHODS: A French teaching hospital infectious diseases database was investigated for all PMNS cases occurring between 1999 and 2016 and the PubMed database for cases reported by other institutions after 1997. A case was defined by the de novo appearance of neurological signs following a post-malaria symptom-free period, a negative blood smear, and no bacterial or viral differential diagnoses. RESULTS: Four patients from the database and 48 from PubMed, including 4 following Plasmodium vivax infection were found matching the definition. In the institution, the estimated PMNS incidence rate was 1.7 per 1000 malaria cases overall. Of the 52 patients (mean age 33 years), 65% were men. Malaria was severe in 85% of cases, showed neurological involvement in 53%, and treated with quinine in 60%, mefloquine in 46%, artemisinin derivatives in 41%, antifolic drugs in 30%, doxycycline in 8% and other types in 8%. The mean symptom-free period was 15 days. PMNS signs were confusion (72%), fever (46%), seizures (35%), cerebellar impairment (28%), psychosis (26%), and motor disorders (13%). Cerebrospinal fluid analyses showed high protein levels in 77% (mean 1.88 g/L) and lymphocytic meningitis in 59.5% (mean 48 WBC/mm(3)) of cases. Electroencephalograms were pathological in 93% (14/15) of cases, and brain MRIs showed abnormalities in 43% (9/21) of cases with white matter involvement in 100%. Fourteen patients were treated with steroids. The 18 patients with follow-up data showed no sequelae. The mean time to recovery was 17.4 days. CONCLUSION: PMNS is a rare entity englobing neurological signs after severe or non-severe malaria. It appears after a symptom-free period. PMNS occurred following treatment of malaria with a wide range of anti-malarials. The disease is self-limiting and associated with good outcome. MRI patterns underline a possible link with acute disseminated encephalomyelitis (ADEM) or auto-immune encephalitis. Plasmodium falciparum and Plasmodium vivax should be added to the list of pathogens causing ADEM. BioMed Central 2018-10-26 /pmc/articles/PMC6204022/ /pubmed/30367650 http://dx.doi.org/10.1186/s12936-018-2542-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Tamzali, Yanis Demeret, Sophie Haddad, Elie Guillot, Hélène Caumes, Eric Jauréguiberry, Stéphane Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework |
title | Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework |
title_full | Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework |
title_fullStr | Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework |
title_full_unstemmed | Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework |
title_short | Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework |
title_sort | post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204022/ https://www.ncbi.nlm.nih.gov/pubmed/30367650 http://dx.doi.org/10.1186/s12936-018-2542-8 |
work_keys_str_mv | AT tamzaliyanis postmalarianeurologicalsyndromefourcasesreviewoftheliteratureandclarificationofthenosologicalframework AT demeretsophie postmalarianeurologicalsyndromefourcasesreviewoftheliteratureandclarificationofthenosologicalframework AT haddadelie postmalarianeurologicalsyndromefourcasesreviewoftheliteratureandclarificationofthenosologicalframework AT guillothelene postmalarianeurologicalsyndromefourcasesreviewoftheliteratureandclarificationofthenosologicalframework AT caumeseric postmalarianeurologicalsyndromefourcasesreviewoftheliteratureandclarificationofthenosologicalframework AT jaureguiberrystephane postmalarianeurologicalsyndromefourcasesreviewoftheliteratureandclarificationofthenosologicalframework |